Blog & News
Follow along for updates and insights on how we’re helping to drive the future of healthcare innovation.
OMNY Health launches new GI real-world data solutions in partnership with leading US gastroenterology practices
OMNY Health’s GI partnerships are a pivotal step in its mission to deliver data and insights to accelerate life-changing innovation. With a focus on catalyzing research and improving outcomes, OMNY aims to make a tangible difference for the millions of individuals in...
OMNY Health launches new GI real-world data solutions in partnership with leading US gastroenterology practices
OMNY Health’s GI partnerships are a pivotal step in its mission to deliver data and insights to accelerate life-changing innovation. With a focus on catalyzing research and improving outcomes, OMNY aims to make a tangible difference for the millions of individuals in...
OMNY Health launches ophthalmology-centric real-world data platform in partnership with leading ophthalmology practices focused on improving patient outcomes
In alignment with OMNY Health’s mission to deliver data and insights to accelerate life-changing innovation, these solutions will serve as a catalyst for research and improved outcomes for the 2+ billion individuals impacted by ophthalmic disease ATLANTA, GA, May 10,...
Register to View Alopecia Areata: Trends in Real-World Treatment Patterns in the United States
On May 15 – May 18, 2022, this poster was on display at ISPOR 2022. What is the Objective of this Poster? Results provide insights into real-world treatment patters for AA within a diverse set of US healthcare settings. ILCS and TCS were by far the most common...
Register to View Hidradenitis Suppurativa in the Pediatric Population
On May 15 – May 18, 2022, this poster was on display at ISPOR 2022. What is the Objective of this Poster? Results provide insight into characteristics and treatments of pediatric HS within a diverse set of US healthcare setting. Acne presented as the most common...
Register to View Hidradenitis Suppurativa: Trends in Real-World Treatment Patterns in the United States
On May 15 – May 18, 2022, this poster was on display at ISPOR 2022. What is the Objective of this Poster? Results provide insights into real-world treatment patterns for HS within a diverse set of US healthcare settings. Adalimumab use has increased steadily since the...
Register to View Detecting Generalized Pustular Psoriasis Exacerbations In Unstructured Clinical Data Using Deep Neural Networks
On May 15 – May 18, 2022, this poster was on display at ISPOR 2022. What is the Objective of this Poster? We were unable to observe higher than 58% accuracy with our NLP model. Nevertheless, this analysis represents an important initial step in developing a more...
Register to View Trends in the Use of Biologics for Treatment of Psoriatic Arthritis
On May 15 – May 18, 2022, this poster was on display at ISPOR 2022. What is the Objective of this Poster? Results provide insights into real-world trends in use of biologics for treatment of PsA. Patient use of biologics increased steadily over the observation period...